Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,540 | 112,672 | 112,765 | 49,865 | 74,293 |
| Marketable Securities | 267,281 | 187,594 | 122,922 | 126,212 | 144,570 |
| TOTAL | $332,897 | $321,218 | $250,149 | $185,785 | $226,979 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 5,108 | 18,793 | 29,414 | 47,683 |
| Other Non-Current Assets | 272 | 229 | 564 | 296 | 280 |
| TOTAL | $272 | $5,337 | $19,357 | $29,710 | $47,963 |
| Total Assets | $333,169 | $326,555 | $269,506 | $215,495 | $274,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,934 | 5,933 | 4,060 | 4,364 | 3,782 |
| Accrued Expenses | 19,997 | 15,569 | 15,478 | 8,451 | 13,330 |
| TOTAL | $25,945 | $21,558 | $19,636 | $12,953 | $17,274 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 14 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $14 |
| Total Liabilities | $25,945 | $21,558 | $19,636 | $12,953 | $17,288 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,202 | 41,281 | 40,569 | 34,213 | 34,016 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -404,641 | -369,097 | -334,119 | -302,720 | -238,333 |
| Other shareholders' equity | 14 | 206 | -18 | -17 | -211 |
| TOTAL | $307,224 | $304,997 | $249,870 | $202,542 | $257,654 |
| Total Liabilities And Equity | $333,169 | $326,555 | $269,506 | $215,495 | $274,942 |